Css LLC Evotec Se Transaction History
Css LLC
- $1.04 Billion
- Q4 2024
A detailed history of Css LLC transactions in Evotec Se stock. As of the latest transaction made, Css LLC holds 12,100 shares of EVO stock, worth $53,724. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,100Holding current value
$53,724% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding EVO
# of Institutions
26Shares Held
2.91MCall Options Held
0Put Options Held
0-
Wellington Management Group LLP Boston, MA2.3MShares$10.2 Million0.0% of portfolio
-
Dcf Advisers, LLC Greenwich, CT230KShares$1.02 Million0.54% of portfolio
-
Morgan Stanley New York, NY126KShares$559,0890.0% of portfolio
-
Black Rock Inc. New York, NY82.6KShares$366,7350.0% of portfolio
-
Goldman Sachs Group Inc New York, NY61.1KShares$271,3630.0% of portfolio
About Evotec SE
- Ticker EVO
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 353,904,992
- Market Cap $1.57B
- Description
- Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare di...